NationsBenefits to Support Sam’s Club Hearing Centers, Supplanting Lucid

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change for clinical practice; this is a retail benefit-administration partnership swap with no direct implications for audiologists' day-to-day patient care.

✦ Why It Matters ✦

Shifts in who administers hearing benefits at large retail chains like Sam's Club can redirect significant patient volume and reshape competitive dynamics between traditional audiology clinics and retail hearing centers.

✦ Key Points ✦

01NationsBenefits is now the hearing-benefit partner for Sam's Club Hearing Centers.
02Lucid has been replaced in the retail hearing-benefit support role.
03The change affects how Sam's Club members access hearing benefits at these locations.
04This reflects ongoing consolidation and competition in the retail hearing-care benefit space.

✦ Related stories ✦

Hearing Review·Industry news·Business & finance·2mo ago

LXE Hearing Announces Wind-Down of US Operations, Affecting Eargo, Lexie, and Go Brands

The collapse of LXE Hearing removes several prominent direct-to-consumer and OTC hearing aid brands from the US market simultaneously, potentially disrupting care for a large number of existing device users and reshaping the competitive OTC landscape.

PubMed·Journal article·Business & finance·3mo ago

Trends in Medicare Reimbursement for the Resection of Vestibular Schwannomas: 2000 to 2021

No immediate change to surgical or audiological practice is warranted; findings highlight coding inconsistencies in Medicare billing for vestibular schwannoma resection that are relevant to surgical billing teams and practice administrators rather than frontline audiologists.

MedWatch·Industry news·Business & finance·2mo ago

US hearing aid company Eargo closes

Eargo's closure removes a notable direct-to-consumer hearing aid brand from the US market, potentially redirecting self-fitting OTC users back toward professional dispensing channels.

Hearing Review·Industry news·Business & finance·2w ago

Amplifon Calls Shareholders’ Meeting to Advance GN Hearing Acquisition

A successful acquisition would combine one of the world's largest hearing-care retail networks with a major hearing-aid manufacturer, potentially reshaping competition, distribution, and pricing across the global audiology market.

MedWatch·Industry news·Business & finance·4w ago

Bankrupt hearing aid company Audientes under police investigation

The collapse and criminal investigation of a hearing aid manufacturer signals potential risks in the sector around startup viability and corporate governance, warranting caution from clinics partnered with smaller or newer device companies.

MedWatch·Industry news·Business & finance·6w ago

GN CEO rejects criticism of “scandalous” sale: “I have great confidence in the board’s decision”

The potential sale of GN Hearing to Amplifon or another buyer could reshape market competition and supply chains in the hearing aid industry, with downstream effects on product availability and clinic partnerships.

Hearing Tracker·Industry news·Business & finance·3mo ago

Amplifon Signs €1.35B Senior Loan to Help Finance GN Hearing Acquisition

If completed, the Amplifon–GN Hearing merger would create one of the most vertically integrated hearing healthcare companies in the world, potentially reshaping manufacturer–retailer relationships, pricing dynamics, and brand availability for independent clinics.

MedWatch·Financial report·Business & finance·3mo ago

Barclays warns that hearing aid market's comeback could be short-lived

A potential softening of the premium hearing aid market could pressure clinic revenue, shift patient mix toward lower-cost devices, and affect manufacturer R&D investment across the field.